GENEVA, June 2 -- LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN, IN VERTRETUNG DES FREISTAATES BAYERN (Geschwister-Scholl-Platz 180539 Munchen) filed a patent application (PCT/EP2024/083251) for "THE COMBINATION OF GM-CSF AND INHIBITION OF CCL22-CCR4 SIGNALING IN THE TREATMENT OF CANCER" on Nov 22, 2024. With publication no. WO/2025/109150, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANZ, David (Abteilung fur Klinische Pharmakologie, LMU KlinikumLindwurmstraBe 2a80337 Munchen), ENDRES, Stefan (Abteilung fur Klinische Pharmak...